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Abstract: The Modified Vaccinia virus Ankara (MVA) is a highly attenuated vaccinia virus serving
as a promising vector vaccine platform to develop vaccines against infectious diseases. In contrast
to the well-established replication deficiency and safety of MVA in mammals, much less is known
about MVA infection in avian hosts. Here, we used a recombinant MVA expressing fluorescent
reporter proteins under transcriptional control of specific viral early and late promoters to study
in vivo tropism, distribution, and pathogenesis of MVA infections in embryonated chicken eggs.
The chorioallantoic membrane (CAM) of embryonated chicken eggs was inoculated with recombinant
MVA, MVA or phosphate-buffered saline. The infection was analyzed by fluorescence microscopy,
histology, immunohistochemistry, and virus titration of embryonic tissues. After infection of the
CAM, MVA spread to internal and external embryonic tissues with the liver as a major target organ.
Macrophages and hematopoietic cells were identified as primary target cells of MVA infection and
may be involved in virus spread. Increasing doses of MVA did not result in increased lesion severity
or embryonic death. Despite MVA generalization to embryonic tissues, the CAM seems to be the
major site of MVA replication. The absence of considerable organ lesions and MVA-associated
mortality highlights an excellent safety profile of MVA in chicken hosts.
Keywords: biodistribution; CAM; chorioallantoic membrane; host range; immunohistochemistry;
poultry; poxvirus; virus propagation
1. Introduction
Modified Vaccinia virus Ankara (MVA) was originally generated by Anton Mayr and Eberhard
Munz in the 1960s [1]. The starting point was a study encompassing serial infection experiments in
cultures of primary chicken embryo fibroblasts (CEF) with a standard vaccinia virus (VACV) strain,
the Chorioallantoic VACV Ankara (CVA), being used for vaccination against smallpox in Turkey
and Germany. After over 516 passages in CEF, a highly attenuated laboratory virus had emerged
which was renamed MVA. The new virus differed from the parental CVA in several biomarkers of
infection including the tropism in cell culture, the behavior in embryonated chicken eggs and the
loss of virulence for mice, and rabbits [2]. The attenuated phenotype of MVA infection is associated
with substantial changes in the viral genome involving large genomic deletions and fragmentation,
truncation and deletion of multiple open reading frames typically found in VACV genomes [3,4].
Viruses 2018, 10, 452; doi:10.3390/v10090452 www.mdpi.com/journal/viruses
Viruses 2018, 10, 452 2 of 14
In consequence, MVA is replication-deficient in mammalian hosts and productively grows in only
a handful of cell cultures [4–9].
Since the 1990s, MVA has been investigated as a safe vector for the development of recombinant
viral vaccines against infectious diseases and cancer. Moreover, MVA is promoted as modern and
safe vaccine against smallpox to replace the earlier and fully replication competent VACV vaccines
(for review, see [10]).
In contrast to the well-established replication deficiency and safety of MVA-based vector vaccines in
mammals, much less is known about MVA infection in avian hosts. Only few studies have been conducted
highlighting the usefulness of recombinant MVA as poultry vaccine against various infectious diseases.
A single intramuscular inoculation of a recombinant MVA vaccine delivering the hemagglutinin antigen of
highly pathogenic avian influenza virus A/Vietnam/1194/04 can protect chickens from a lethal challenge
with a high dose of highly pathogenic A/duck/Vietnam/TG24-01/2005 [11]. Vaccination with an ancestral
hemagglutinin H9 antigen delivered by recombinant MVA was evaluated against low pathogenic avian
influenza virus subtype H9N2 infection in the chicken model [12]. Furthermore, an MVA vector vaccine
expressing the capsid protein VP2 of infectious bursal disease virus is tested as a candidate vaccine
in chicken [13,14]. Further experimental studies attempted in ovo vaccinations using an adenovirus
and recombinant MVA expressing avian influenza T cell antigens. Upon vaccine regime optimization,
MVA vector vaccine was inoculated into the amniotic cavity of the embryonated chicken egg and no
adverse effects were observed [15]. Overall, however, there is still very little experience with regard to
MVA infection and MVA distribution in chickens.
Although MVA has been adapted to grow in chicken cells and MVA vaccines have been amplified
in embryonated eggs [16], MVA infection of the chicken embryo has not been studied in detail using
modern methodologies.
Here we studied the in vivo tropism, distribution, and pathogenesis of MVA infections in
embryonated chicken eggs. We took advantage of an MVA vector expressing two fluorescent reporter
proteins and used whole organ imaging, virus titration, histology and immunohistochemistry to
monitor the outcome of infections with various amounts of MVA. We show that MVA infection of
chicken embryos leads to a generalized spread of virus and to the infection of several types of cells,
including macrophages, hepatocytes and cells of the hematopoietic tissues. Surprisingly, MVA infection
seems to be well tolerated because even high dose inoculations did not lead to increased incidence of
embryonic death.
2. Materials and Methods
2.1. Viruses
To follow MVA distribution in the chicken embryo, a previously characterized recombinant
MVA-GFP-mCherry was used as a reporter virus [17]. Briefly, this recombinant virus was
generated using standard methods and a clonal isolate (F6) of MVA as the backbone virus [18].
MVA-GFP-mCherry expresses synthetic gene sequences encoding a green fluorescent protein (GFP)
under transcriptional control of the vaccinia virus (VACV)-specific early promoter Pvgf and a red
fluorescent protein (mCherry) regulated by the VACV-specific late promoter P11. The MVA clonal
virus isolate F6 (MVA) served as non-recombinant infection control. Phosphate-buffered saline (PBS)
served as a negative control.
2.2. Egg Preparation and CAM Infection
Fertilized eggs from a specific-pathogen-free (SPF) chicken flock (Valo Biomedia, Osterholz-
Scharmbeck, Germany) were stored at 16 ◦C for two days prior to incubation. Eggs were incubated at
37.9 ◦C and 45% humidity in an incubator (MP GTFS, Grumbach, Schwabach) with automated turning
of eggs. Eggs were inoculated at embryonic day 11 (ed11) of incubation. Shells were wiped with ethanol
and perforated over the air chamber with a power tool. At the inoculation site, a small triangle of
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the shell was removed. Using a sterile fine dosage syringe with a 30G needle, the shell membrane
was perforated and 100 µL of inoculum deposited between the CAM and the inner shell membrane.
The hole in the shell was sealed with a transparent tape (Tesafilm, tesa SE, Norderstedt, Germany) and
the eggs further incubated without automated rotation to promote sterility at the inoculation site.
Eggs were CAM-inoculated with 103 infectious units (IU) MVA or MVA-GFP-mCherry per embryo.
Control embryos were mock-infected with PBS. On days 2–7 post inoculation (2–7 dpi), embryos were
necropsied. The experiments were carried out in accordance with institutional and national guidelines
for work with genetically modified organisms. No ethical approval was required for this study.
2.3. Necropsy and Imaging
At necropsy, the following organs were imaged: Brain, CAM, gonads, heart, intestines, kidneys,
liver, lung, proventriculus, spleen, ventriculus, and yolk sack. Proliferative nodules (pocks) on the
CAM were scored according to their size: small: ≤1 mm; moderate: 2–5 mm; large: >6 mm.
Organs of MVA-GFP-mCherry infected embryos on petri dishes were examined with
a ChemiDoc™ MP Imaging system (Bio-Rad Laboratories) and the MacroIllumination Imaging System
(Lightools, Encinitas, CA, USA).
Images of native tissue preparations, histological and immunohistochemical slides were taken
with an inverted fluorescence microscope (Keyence BZ-X700, Keyence, Neu-Isenburg, Germany) with
GFP filter (excitation wavelength 470/40 nm, absorption wavelength 525/50 nm), TexasRed filter
(excitation wavelength 560/40 nm, absorption wavelength 630/75 nm), and DAPI filter (excitation
wavelength 360/40 nm, absorption wavelength 460/50 nm).
After imaging, CAM and organs were processed for histologic examination and viral titration.
2.4. Histology and Immunohistochemistry
Tissues for histology were routinely paraformaldehyde-fixed, paraffin-embedded, cut and sections
stained with hemalum-eosin.
To keep the tension of the CAM during fixation and embedding process, CAMs were dissected
with a modified version of Voss’ technique [19]. The fenestration of the eggshell was enlarged
and CAMs were clamped between two metal washers taped to a forceps. CAMs were extracted,
the two washers disconnected from the forceps and the CAMs including the washers were fitted
into an embedding cassette and fixed with a clip. CAMs were trimmed after embedding. CAMs for
Kul01-immunhistochemistry (IHC) were fixed in zinc-salt fixative [20].
IHC was performed with preceding avidin-biotin-block and without epitope retrieval [21].
For macrophage detection, a mouse monoclonal antibody was used (1:100, Kul01, Southern Biotech,
8420-01, Birmingham, AL, USA). For MVA detection, a polyclonal rabbit anti-vaccinia antiserum
was used (1:1000, Acris, BP1076, Herford, Germany). Biotinylated secondary antibodies were
a goat-anti-mouse Fab-fragment (1:200, Jackson Immunoresearch, 115-067-003, Cambridge, UK) and
a goat anti-rabbit antibody (1:200, Vector, BA-1000, Burlingame, CA, USA). Peroxidase-complexed
avidin-biotin (ABC-HRP, Vector, PK-6100) and diaminobenzidine were used as visualization and
hemalum as counterstain. MVA-Kul01-double-IHC was done sequentially, first MVA-IHC with
Streptavidin Alexa Fluor 568 (1:100, ThermoFisher, S-11226, Waltham, MA, USA), followed by
avidin-biotin-block and Kul01-IHC with ABC-HRP and tyramide signal amplification with Alexa
Fluor 488 (ThermoFisher, B40953) and nuclear DAPI-staining. Mouse IgG (Vector, I-2000) and
rabbit-anti-Escherichia coli (B0357, Dako, Hamburg, Germany) were used as negative controls.
Tissues containing macrophages (Kul01-IHC: spleen, bursa) or orthopoxviruses (MVA-IHC) served as
positive controls.
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2.5. Virus Titration
Organs of chicken embryos were weighed, freeze-thawed three times and homogenized with PBS
in a microtube for 45 s at lowest level (Retsch TissueLyser MM 300; Qiagen GmbH, Hilden, Germany).
After centrifugation (1 min; 1500 rpm; 4 ◦C), supernatants were stored at −80 ◦C.
Virus infectivities were determined via routine plaque assays performed in duplicate [18].
In 6-well-plates, confluent CEF monolayers were infected with serial 10-fold dilutions of the organ
supernatants. After two hours at 37 ◦C, the cells were washed with PBS. After washing, cells were
incubated at 37 ◦C for two days with virus growth medium [18]. The infected cells were fixed with
acetone-methanol and incubated with polyclonal rabbit anti-vaccinia antiserum (1:1000, Acris, BP1076),
followed by peroxidase-conjugated goat anti-rabbit antibody (1:5000, Jackson ImmunoResearch,
111-035-035). Infectious foci were visualized with TrueBlue, counted, calculated, log10-transformed,
and indicated in IU/g organ.
2.6. Serum Analysis
For serum analysis, embryonated eggs were CAM inoculated with 109 IU MVA or MVA-
GFP-mCherry and blood samples were collected by piercing the chorioallantoic veins at 4 dpi with
a 30G needle connected to a fine dosage syringe. Serum samples were stored at −80 ◦C. Sera were
diluted with saline to obtain a minimal amount of 100 µL and enzyme activities were calculated
for the original concentration. Six of eleven undiluted sera were analyzed in parallel to control
dilution. Aspartate transaminase (AST), glutamate dehydrogenase (GLDH), and lactate dehydrogenase
(LDH) activities were analyzed with a Cobas Integra 400 plus (Roche, Grenzach-Wyhlen, Germany)
at the laboratory of the Clinic of Small Animal Medicine, Centre for Clinical Veterinary Medicine,
LMU Munich.
2.7. Data Analysis
Statistical tests and calculations were performed with Microsoft Excel (Microsoft Office 2016,
Redmond, WA, USA) and GraphPad Prism version 5.04 for Windows (GraphPad Software, La Jolla,
CA, USA).
3. Results
3.1. MVA Infection of the Chorioallantoic Membrane (CAM) in Chicken Eggs
Following established methodology for CAM infections with poxviruses [22], we inoculated 103
IU MVA or MVA-GFP-mCherry and started with the characterization of the infection site.
As early as 2 dpi, MVA inoculated CAMs displayed defined areas of multiple white,
proliferative nodules with diameters of ~1.0–3.5 mm (pock lesions; Figure 1a). In MVA-GFP-mCherry
inoculated CAMs, we found these pock lesions to be consistently associated with the detection of green
and strong red fluorescence (Figure 1b,c). These lesions were clearly orientated along the vascular
trees, and in some of the embryonated eggs, we observed the development of secondary pocks on
the CAM distant from the primary site of infection. The detection of green and red fluorescence in
CAM tissues indicated the production of the fluorescent reporter proteins and thus the unimpaired
expression of early and late classes of viral genes. In addition, the finding of substantial virus loads in
CAMs infected with MVA or MVA-GFP-mCherry confirmed the productive replication of the viruses
(Figure 1d).
Histological and immunohistochemical examination revealed considerable changes in the MVA
infected CAM tissues including proliferation of resident cells (see below) and the presence of
large numbers of inflammatory cells mainly consisting of macrophage-like cells and granulocytes.
The proliferation of resident cells and the massive cellular influx at the site of the pock lesion
increased the thickness of the CAM about 40-fold to ~1100 µm, compared to the ~25 µm thickness of
normal CAM (Figure 2a,b). Moreover, due to the expansion of the pock lesions, the CAM partially
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separated from the shell membrane. The normally double-layered ectoderm was hyperplastic and
contained many transmigrating macrophages and granulocytes targeting the inoculum between the
ectoderm and the shell membrane. Later in infection, the ectoderm displayed cellular hypertrophy,
pronounced hyperplasia, flattening of superficial cells and detachment from the basal layer. In large
pocks, multiple newly-formed epithelial islands were found in the mesoderm. The mesoderm was
considerably thickened, edematous and infiltrated by moderate to large numbers of granulocytes and
macrophages. We detected multifocal angiogenesis and dilated mature vessels displaying intravascular
leukocyte margination. Even early in infection, we found considerable proliferation of fibroblasts
in the mesoderm leading to deposition of collagen fibers in late infection. Overall, the entodermal
reactions to infection were less pronounced and consisted of only mild hyperplasia.
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Figure 1. MVA-infection, chicken chorioallantoic membrane; (a) CAM, 4 dpi, multiple pocks along
the vascular tree, bar = 5 mm; (b) CAM, 4 dpi, red fluorescence the same pocks, bar = 5 mm;
(c) CAM, 3 pi, native preparation on a slide, green and red fluorescence of two pocks, bar = 100 µm;
(d) scatter ot plot of MVA titers in the CAM after infection with 103 IU. The lines represent medians,
nd = not detected.
Using immunohistochemistry, MVA antigen was detected at 2 dpi in the cytoplasm of ectodermal
and mesodermal cells i cluding many putative macrophages and to a lesser extent fibroblasts
(Figure 2c). We also detected mCherry antigen in the same cells, corroborating the resu ts of
the MVA-IHC and the fluorescenc exp rime ts. Positive stain ng using Kul01-MVA-double-IHC
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suggested that the majority of MVA antigen-positive cells were macrophages (Figure 3a–c) confirming
Kul01+ macrophages as main target cells for MVA infection in the CAM.
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Figure 2. Histology of MVA-infection, chicken chorioallantoic membrane; (a) CAM, normal, from top:
thick inner shell membrane, single layer of ectoderm with interwoven capillaries, mesoderm with
vessel, single layer of entoderm, bar = 50 µm; (b) CAM, 7 dpi, pock lesion with massive thickening of
ectoderm and m soderm, bar = 500 µm; (c) CAM, 2 dpi, MVA-immunohist chemistry (IHC), thickening
of mesoder with inflammation and MVA antigen (brown) in mesoderm, bar = 100 µm (d–f) CAM,
4 dpi, Kul01-vaccinia virus-double-IHC, macrophages (Kul01+; green) containing MVA antigen (red),
in the overlay displayed yellow, nuclear staining with DAPI, bar = 50 µm.
3.2. MVA Spread to the Chicken Embryo and the Extraembryonic Tissues
To assess MVA spread from the CAM as the primary site of infection, we analyzed the
embryonic organs and extraembryonic tissues for signs of viral replicati n using the reporter virus
MVA-GFP-mCherry. On day 3 pi, we observed multifocal miliary red-fluorescent pots randomly
distributed in ~10% of the livers. These red-fluorescent foci also contained fewer cells displaying
green fluorescence as revealed upon microscopic examination (Figure 3a,b). Using histology and
immunohistochemistry, we clearly detected MVA infected hepatocytes as evidenced by virus antigen
being multifocally and randomly distributed within the cytoplasm of the infected cells (Figure 3c).
Moreover, some virus-infected hepatocytes demonstrated typical signs of necrosis and were clearly
associated with macrophage-like cells and/or granulocytes. Most MVA antigen-positive cells, however,
were without signs of inflammation or detectable cellular injury. We also detected mCherry antigen
in hepatocytes, corroborating the expression of late viral gene and the results of t e MVA-specific
IHC and the imaging exper ments. The finding of MVA inf cted liver cells supported the generalized
spread of from the inoculation site to the liver. To further confirm a generalized MVA
infection, we analyzed viral loads in livers and lungs and found 102 to 104 IU/g tissue MVA or
MVA-GFP-mCherry in livers and lungs of most infected embryos (Figure 3d,e). Interestingly, when we
correlated log10-transformed virus titers from CAM and liver, we identified a significant moderate to
strong positive correlation (Pearson-correlation; 103 IU: r = 0.75, p = 0.001). The correlation of high
MVA titers in the CAM with high MVA titers in the liver suggested a direct connection between the
infections of these two embryonic tissues.
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However, we failed to detect red fluorescence when imaging other organs of the chicken embryos.
To characterize the putative spread of MVA infection in more detail, we assessed a large set of
organ samples from infected embryos by histology and immunohistochemistry. Indeed, already at
2 dpi we found cell-associated MVA antigen in the tissues of bursa fabricii, heart, intestines, kidneys,
skeletal muscle, skin, and ventriculus in many different cell types including endothelial cells, fibroblasts,
myocytes (cardio-, leio-, rhabdo-), and glomerular mesangial cells. Moreover, we detected MVA antigen
in hematopoietic cells in the yolk sack and the bone marrow. Both extravascular (granulopoiesis) and
intravascular (erythropoiesis) hematopoietic cells displayed cytoplasmic MVA antigen (Figure 3f).
In the bone marrow and yolk sack, we detected few overall cytopathic effects with rare detection
of karyorrhexis and single cell necrosis. Additionally, we found single intravascular hematopoietic
precursor cells containing cytoplasmic MVA antigen suggesting vascular distribution of the virus
through different organs, already at early points of infection (2 dpi, Figure 3f, inset). Furthermore,
mainly in liver and lung, the perivascular foci of heterophilic granulopoiesis were mildly to moderately
expanded, probably as a result of an increased inflammation of the CAM. Mock-infected control
embryos occasionally displayed mild hemorrhage or inflammation at the inoculation site, but were
without lesions or MVA antigen in any tissues or organs.
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Figure 3. MVA-infection, chicken embryo; (a) Liver, 3 dpi, multifocal random red-fluorescent spots,
bar = 5 mm; (b) Liver, 3 dpi, native preparation on a slide, green and red fluorescence of foci, hepatocyte
autofluorescence in blue, bar = 100 µm; (c) Liver, 2 dpi, MVA antigen in hepatocytes, MVA-IHC,
bar = 50 µm; (d,e) Scatter dot plot of MVA titers in the liver and lung after infectio with 103 IU.
The lines represent edians, nd = not detected (f) Bon marrow, 6 dpi, intra- and extravascular
hematopoietic cells with MVA antigen, inset: 2 dpi, circulating hematopoietic cell in the liver, MVA-IHC,
bar = 50 µm.
Interestingly, we noticed another macroscopic alteration in the infected livers. Starting at 5 dpi,
livers of MVA-infected embryos (Figure 4a), and in some animals also kidneys and allantoic fluid,
displayed a clearly visible green color. Other macroscopic overt signs of infection or gross lesions
were not detected. In histologic sections, from 3 dpi on, we detected many Kupffer cells performing
multifocal erythrophagocytosis. From 4 dpi on, consistently, Kupffer cells contained cytoplasmic bile
pigment, and bile plugs were detected in canaliculi and small bile ducts (Figure 4b). These histological
findings are consistent with the macroscopic observations in livers suggesting cholestasis in the
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liver and subsequent hyperbiliverdinemia as cause of the green color of the embryonic liver after
MVA infection.
As we did not detect overt hepatocyte damage histologically, we further monitored for potential
liver damage and comparatively analyzed activities of liver enzymes in four mock infected and six
MVA infected embryos. As a positive control, we used an independently selected chicken embryo
with macroscopically and histologically confirmed liver necroses. Aspartate transaminase (AST),
glutamate dehydrogenase (GLDH), and lactate dehydrogenase (LDH) activities were within normal
variation and displayed no major or significant differences (Mann Whitney test, p > 0.17–0.91) between
PBS inoculated and MVA infected chicken embryos (Figure 4c). In contrast, the embryo with histologically
confirmed liver necroses displayed a 10-fold increase of AST activity (465 U/L), 198-fold increase of
GLDH activity (183 U/L), and 21-fold increase of LDH activity (9291 U/L) when compared to mean
enzyme activities of PBS inoculated embryos.
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3.3. Egg Infections Using Escalating MVA Doses
Since the data so far indicated a generalized spread of MVA after CAM inoculation, we assessed
the effect of increasing doses of MVA or MVA-GFP-mCherry with regard to pathological findings and
mortality in the chicken embryos. We infected embryonated eggs with 103, 105, or 107 IU, candled the
eggs twice daily, and analyzed the embryonated eggs after generalization of infection at the time point
4 dpi.
The infections with the three MVA doses induced the formation of pock lesions in the CAM
with comparable sizes ranging in diameter between 2–5 mm. A significant increase in lesion
size corresponding to escalating inoculation doses was not detected. Pearson’s correlation of
log10-transformed viral titer in the CAM with pock lesion size was performed in the three dosing groups.
There was no significant correlation (r = 0.15–0.41, p = 0.13–0.60). In addition, there were no detectable
differences when comparing the lesion sizes induced by MVA or MVA-GFP-mCherry infections.
Upon pathological examination of the infected chicken embryos, we once again found no major
change in gross lesions associated with the inoculation of different amounts of virus. Of note, until the
day of analysis none of the 52 infected embryos had died from the infection. When monitoring the
internal organs, the green color of livers seemed more intense in embryos inoculated with the higher
doses of 105 or 107 IU MVA or MVA-GFP-mCherry. Analogously, we detected a higher number of foci
of erythrophagocytosis and more accumulations of bile pigment in canaliculi and ducts in the liver
sections from these animals.
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Finally, we determined viral loads in CAMs, livers and in selected embryonic organs such as yolk
sack, kidney and brain (Figure 5). Overall, the infections with MVA or MVA-GFP-mCherry resulted in
very comparable amounts of infectious virus detectable in all organs. Overall, CAM and liver tissues
contained the highest loads of infectious virus (Figure 5a). When we correlated log10-transformed
viral loads in CAMs and livers in 105 and 107 IU inoculated embryonated eggs, there was a significant
moderate positive correlation (Pearson correlation; 105 IU: r = 0.52, p = 0.032; 107 IU: r = 0.61, p = 0.005).
Lower viral titers were found in yolk sack, kidney and brain (Figure 5b). Yet, the presence of readily
detectable infectious virus in the majority of the samples indicated a generalized distribution of the
viruses in the whole chicken embryo.
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of host cells were found permissive for infection and may support the spread of the virus within the
chicken embryo.
MVA is a well-established third generation smallpox vaccine and serves as a promising viral
vector for the development of candidate vaccines against infectious diseases or cancer [10]. After serial
cell culture passages on CEFs, MVA was adapted to grow in avian cells and lost the ability to replicate
productively in mammalian hosts [2,4]. However, there is still relatively little known about the
pathogenesis and biodistribution of MVA in an avian host. This information, however, is important
with regard to poultry vaccine development as well as to estimate a potential risk for the general
environment in case of an unintentional release of genetically modified MVA vaccines [23]. Moreover,
a more detailed understanding about the tropism of MVA in chicken might contribute to further
elucidate poxvirus gene functions involved in the regulation of virus-host interactions.
Before the routine availability of cell culture methods, virologists often used infections of
embryonated chicken eggs to amplify, titer, and characterize viruses. For poxviruses, the most common
method was the CAM inoculation [24–26]. The histologic architecture of the CAM, three germinal
layers consisting of ectoderm, mesoderm and entoderm, provides a broad range of different cell types
as suitable viral targets. Thus, we used CAM inoculations to study the distribution, tissue tropism
and cellular tropism of a recombinant MVA expressing green and red fluorescent proteins as specific
markers for key steps in the VACV life cycle [17]. We confirmed unimpaired expression of MVA
early and late genes upon infection of the CAM, when we detected green and red fluorescent
cells in primary and secondary pock lesions. Productive MVA infection was further supported
by immunohistochemistry and analysis of viral loads in the CAM. We detected ample amounts
of viral antigen within the mesoderm of the CAM and an increase in viral load. Using the low
infectious dose of 103 IU, MVA seemed to multiply somewhat more efficiently in the CAM when
compared to MVA-GFP-mCherry. As both viruses demonstrate identical growth properties in tissue
culture [17], this observation may indicate that the expression of the two marker genes influences
MVA-GFP-mCherry replication in an egg infection. Applying higher infectious doses for infection and
monitoring viral load in other tissues we observed about equal titers of MVA and MVA-GFP-mCherry.
Yet, the monitoring of replicative capacity needs further attention in other in vivo infection studies
using MVA-GFP-mCherry.
With the use of a zinc-salt dependent fixative, which preserves fixation-sensitive epitopes [27,28],
we demonstrated that MVA mainly targets Kul01+ macrophages [29] in chicken embryos. The preference
of MVA for infection of human peripheral blood mononuclear cells (PBMC)-derived monocytes
and dendritic cells is well-known from in vitro studies [30,31]. Recently, in vivo experiments also
demonstrated the direct targeting of such antigen presenting cells in mice, ferrets and non-human
primates [32]. When considering the potential of MVA vector vaccines for immunization of poultry
or in ovo vaccination, the targeting of avian antigen presenting cells could also be beneficial to elicit
an effective immune response.
The production of the fluorescent marker proteins allowed tracking of MVA within the embryo.
At 3 dpi, green and red fluorescent foci in the liver initially indicated the infection of hepatic tissues
and the generalized spread of MVA from the CAM as the primary site to the chicken embryo.
Using immunohistochemistry, we identified hepatocytes as main MVA target cells in the liver and the
titration of infectious virus in liver tissues suggested a productive MVA infection. The correlation of
MVA titers in CAM and liver tissues further support the assumption that MVA is spreading from the
CAM directly to the liver via the blood stream.
This is in line with our observation that primary pock lesions in the CAM are mostly located next
to the vascular trees of the membrane. Developing from ed4 to ed12 the CAM becomes the major
site of respiration in the avian embryo until ed19 [33]. Blood is oxygenated extraembryonically in
the CAM and flows via the chorioallantoic vein into the embryo through the liver into the heart [34].
Our finding of MVA infection in hematopoietic cells further bolstered the hypothesis that MVA is
distributed via the blood stream, because these cells are the progenitors of all blood cells. Furthermore,
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during development, these hematopoietic cells move between different compartments in the chicken
embryo in a complex manner [35,36]. Finally, the detection of MVA-infected circulating hematopoietic
cells within blood vessels corroborated that MVA is distributed via the blood stream to extraembryonic
and embryonic tissues.
Apart from direct MVA infection of hepatocytes, the green color of the infected liver was another
striking observation. The green color originated from canalicular and small ductular bile cholestasis
and storage of bile pigment in Kupffer cells. Birds lack biliverdin reductase, thus the final product
of avian heme catabolism and the predominant bile pigment is biliverdin [37]. Bile storage in
Kupffer cells can be due to increased erythrophagocytosis and heme catabolism or regurgitation
of bile pigments by hepatocytes. We ruled out obstructive cholestasis in the chicken embryos,
because gall bladders and large bile ducts were normal and ductular reactions were not detected [38].
As histology and serum chemistry revealed at the most minor hepatocyte damage, cholestasis is
likely not caused by hepatocyte damage but directly attributed to generalized infection. In mammals
including humans, there is a so called “cholestasis of sepsis”, in which systemic pro-inflammatory
cytokines like IL-1β and TNF-α lead to downregulation of bile acid transporter proteins and to
canalicular and ductular cholestasis [39]. Typically, serum liver enzymes are not elevated and
hepatocellular injury is absent. Increased breakdown of erythrocytes by intravascular or extravascular
hemolysis can contribute to increased bile pigment production [40]. Viral infection of macrophages
can lead to dramatically increased synthesis of pro-inflammatory cytokines in different species [41–43].
Interestingly, MVA-infected murine and human macrophage-like cells activate a robust chemokine
production but a fairly weak inflammatory response. Hereby, bioactive IL-1β produced in response
to MVA infection is effectively neutralized by the MVA encoded viral IL-1β-receptor protein [44–46].
Thus, it is tempting to speculate that the observed cholestasis is a consequence of a generalized
inflammatory reaction possibly supported by a malfunction of orthopoxviral inhibitor protein(s) in the
infected chicken embryos. Surprisingly, viral loads in the liver were reduced in embryonated eggs
infected with 107 IU of MVA and MVA-GFP-mCherry when compared with those from eggs infected
with 103 or 105 IU of MVA. This observation might be correlated with an increased accumulation of
bile constituents in the liver, which might interfere with in vivo or in vitro growth of MVA.
Overall, the inflammatory reaction to MVA infection predominantly consisted of the infiltration
of granulocytes and macrophages and the expansion of granulopoiesis in liver and lung.
This observation is somewhat untypical for a viral infection, which usually features lymphohistiocytic
or lymphoplasmacytic infiltrates. Yet, inoculation of other orthopoxviruses on chicken embryo CAMs
can result in a similar response. The white pock lesions in cowpox virus infections are largely comprised
of granulocytes [47]. At the embryonic stage of our experimental infection (ed11), the embryonic
acquired immune system is not fully functional, because colonization of lymphoid organs partially
occurs at later time points, e.g., the thymus is colonized in three distinct waves on ed6.5, ed12,
and ed18 [35]. In addition, chicken embryonic and early post-hatch T-cell responses are reduced when
compared to those in chickens at later time points [48–50].
In 1975, Mayr and colleagues investigated the outcome of CAM inoculations with MVA or CVA.
In comparison to CVA, the pock lesions of MVA on the CAM lacked typical morphology of necrosis,
a significantly reduced rate of embryonic death was reported (40% compared to 100% with CVA)
and embryonic skin lesions did not form upon MVA inoculation [2]. Also in our dose escalation
study, we determined a clearly low virulence of MVA for chicken embryos. Even infections with
the highest dose of 107 IU MVA per embryo did not result in embryonic death. This is surprising,
when considering that MVA does productively replicate and efficiently spread in the chicken embryos.
Moreover, these chicken embryos are naturally immunocompromised during their ontogenesis, e.g.,
due to the lack of mature thymocyte responses [50]. Thus, these results support an exceptional safety
profile of MVA and the MVA vaccine delivery system in chicken hosts as well.
Indeed, these findings are highly encouraging to further investigate the usefulness of recombinant
MVA as vaccine vector system for immunization of birds and poultry including in ovo vaccination.
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In a first in ovo vaccination study in chicken using recombinant MVA, the authors did not observe
any adverse effects, but distribution and pathogenesis of MVA infection were not examined [15].
The thorough investigation of MVA vaccine safety, immunogenicity and efficacy including the
use of commercial egg injection machines and cost-efficient vaccination doses will clearly require
further studies.
In summary, CAM inoculation represents an excellent model to study distribution and
pathogenesis of different infectious agents, because the CAM is a highly vascularized organ,
which functions as major site of gas exchange for the developing chicken. Main target cells of
MVA infection in chicken embryos are Kul01+ macrophages, hematopoietic cells and hepatocytes.
MVA doses up to 107 IU do not lead to increased mortality, highlighting an excellent safety profile of
this attenuated VACV. The chicken embryo infection may also be useful as a model to study virus–avian
host interactions. In particular, it might be promising to reassess the function of poxviral proteins
known to modulate innate responses of the mammalian immune system. Finally, first promising
results from experimental MVA vaccination in poultry and the replication competence of MVA in the
embryonated egg support future studies in vaccine development including in ovo vaccination.
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